Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie L Prior

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Theranostics|January 16, 2025
Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticlesHengbo Huang, Lei Fang, Janaka Wansapura, et al.
Molecular and Cellular Biology|August 25, 2010
Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesisJochen K Lennerz, Jonathan B Hurov, Lynn S White, et al.
Blood|December 4, 2008
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Bruno Nervi, Pablo Ramirez, Michael P Rettig, et al.
Journal of Cellular Biochemistry|February 9, 2008
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in miceOzge Uluçkan, Mark C Eagleton, Desiree H Floyd, et al.
Cancer Research|June 5, 2023
Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug ResistanceXiaoqing Cheng, Yirui Sun, Maureen Highkin, et al.
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab DeruxtecanXiaoqing Cheng, Jacob Hsia, Jesus Iraheta, et al.
Bone|May 16, 2009
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclastsAngela C Hirbe, Anke J Roelofs, Desiree H Floyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivoJonathan B Hurov, Mei Huang, Lynn S White, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 26, 2009
Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunitElizabeth A Morgan, Jochen G Schneider, Timothy E Baroni, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Theranostics|January 16, 2025
Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticlesHengbo Huang, Lei Fang, Janaka Wansapura, et al.
Molecular and Cellular Biology|August 25, 2010
Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesisJochen K Lennerz, Jonathan B Hurov, Lynn S White, et al.
Blood|December 4, 2008
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Bruno Nervi, Pablo Ramirez, Michael P Rettig, et al.
Journal of Cellular Biochemistry|February 9, 2008
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in miceOzge Uluçkan, Mark C Eagleton, Desiree H Floyd, et al.
Cancer Research|June 5, 2023
Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug ResistanceXiaoqing Cheng, Yirui Sun, Maureen Highkin, et al.
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab DeruxtecanXiaoqing Cheng, Jacob Hsia, Jesus Iraheta, et al.
Bone|May 16, 2009
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclastsAngela C Hirbe, Anke J Roelofs, Desiree H Floyd, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivoJonathan B Hurov, Mei Huang, Lynn S White, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 26, 2009
Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunitElizabeth A Morgan, Jochen G Schneider, Timothy E Baroni, et al.
Pageof 6